Taysha Gene Therapies, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC TSHA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,902,978

Value ($000)

10,466

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	10,466	0.0%	1,902,978	12/31/2025
2025 Q3	11/10/2025	6,038	0.0%	1,846,510	9/30/2025
2025 Q2	8/12/2025	1,136	0.0%	491,709	6/30/2025
2025 Q1	9/15/2025	761	0.0%	547,128	3/31/2025
2024 Q4	2/6/2025	820	0.0%	474,257	12/31/2024
2024 Q3	11/12/2024	930	0.0%	462,867	9/30/2024
2024 Q2	8/12/2024	963	0.0%	429,744	6/30/2024
2024 Q1	5/9/2024	148	0.0%	51,462	3/31/2024
2023 Q4	2/6/2024	29	0.0%	16,140	12/31/2023
2023 Q3	11/8/2023	51	0.0%	16,140	9/30/2023
2023 Q2	8/10/2023	11	0.0%	16,140	6/30/2023
2023 Q1	5/12/2023	13	0.0%	16,140	3/31/2023
2022 Q4	2/13/2023	36	0.0%	16,140	12/31/2022
2022 Q3	11/14/2022	32	0.0%	16,140	9/30/2022
2022 Q2	8/15/2022	338	0.0%	90,711	6/30/2022
2022 Q1	5/13/2022	1,079	0.0%	165,345	3/31/2022
2021 Q4	2/11/2022	1,894	0.0%	162,560	12/31/2021
2021 Q3	11/16/2021	2,950	0.0%	158,407	9/30/2021
2021 Q2	8/16/2021	1,846	0.0%	87,030	6/30/2021
2021 Q1	5/17/2021	1,183	0.0%	58,243	3/31/2021
2020 Q4	2/16/2021	1,387	0.0%	52,232	12/31/2020